Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
Chonghui Hu, Renpeng Xia, Xiang Zhang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
Qin Qin, Rong Yu, John Eriksson, et al.
Cancer Letters (2024) Vol. 591, pp. 216859-216859
Open Access | Times Cited: 22
The regulatory relationship between transcription factor STAT3 and noncoding RNA
Siyi Liu, Wentao Li, Lin Liang, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 17
Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan J. Reshkin, Tiago M. A. Carvalho, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2486-2486
Open Access | Times Cited: 67
Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes
Katherine Richards, Weikun Xiao, Reginald Hill
Cancers (2022) Vol. 14, Iss. 11, pp. 2812-2812
Open Access | Times Cited: 43
Fibroblasts in pancreatic cancer: molecular and clinical perspectives
Rita Rebelo, Cristina P. R. Xavier, Elisa Giovannetti, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 6, pp. 439-453
Closed Access | Times Cited: 41
Regulation of the tumor immune microenvironment by cancer-derived circular RNAs
Liping Guan, Qian Hao, Fenfen Shi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 24
Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment
Karl Knipper, Su Ir Lyu, Alexander Quaas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13482-13482
Open Access | Times Cited: 23
hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma
Lei Xu, Xiao Ma, Xiuzhong Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Overcoming therapy resistance in pancreatic cancer: New insights and future directions
Margarita Espona‐Fiedler, Cédric Patthey, Stina Lindblad, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116492-116492
Open Access | Times Cited: 10
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
Keping Deng, Fang Zou, Jin Xu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 3, pp. 524-537
Closed Access | Times Cited: 9
The role of transcription factors in the crosstalk between cancer-associated fibroblasts and tumor cells
Xiaoyan Zhang, Meng Zhang, Hui Sun, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 9
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation
Rihua He, Chonghui Hu, Yuan Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 21
Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer
Shangyou Zheng, Qing Tian, Yuan Yuan, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 20
AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis
Yangjun Wu, Miao Xu, Zheng Feng, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 9
Closed Access | Times Cited: 19
Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications
Zhengjun Lin, Guoqing Li, Ke Jiang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 7
Role of the Tumor Microenvironment in Regulating Pancreatic Cancer Therapy Resistance
Daiyong Deng, Riya Patel, Cheng-Yao Chiang, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2952-2952
Open Access | Times Cited: 27
Targeted therapy and drug resistance in thyroid cancer
Yujie Zhang, Zhichao Xing, Tianyou Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114500-114500
Closed Access | Times Cited: 26
A phosphoglycerate mutase 1 allosteric inhibitor overcomes drug resistance to EGFR-targeted therapy via disrupting IL-6/JAK2/STAT3 signaling pathway in lung adenocarcinoma
Qian Liang, Miaomiao Gong, Jing-Hua Zou, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100957-100957
Open Access | Times Cited: 13
Noncoding RNAs in tumorigenesis and tumor therapy
Pingping Zhu, Benyu Liu, Zusen Fan
Fundamental Research (2023) Vol. 3, Iss. 5, pp. 692-706
Open Access | Times Cited: 13
Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies
Wenhui Jia, Zhao Huang, Li Zhou, et al.
Drug Resistance Updates (2023) Vol. 70, pp. 100988-100988
Open Access | Times Cited: 13
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Olamide Tosin Olaoba, Ming Yang, Temitope Isaac Adelusi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1470-1470
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top